Filtered By:
Condition: Heart Valve Disease
Countries: Poland Health

This page shows you your search results in order of date.

Order by Relevance | Date

Total 7 results found since Jan 2013.

Nationwide experience with transcarotid transcatheter aortic valve implantation: Insights from the POL-CAROTID registry
CONCLUSIONS:: The results of the study indicated that the first cohort of transcarotid transcatheter heart valves of second-generation implantations in Poland were associated with a similar prognosis to TF-TAVI with regard to safety and feasibility. TC access may be considered an optimal alternative for patients, in whom the TF approach is precluded.PMID:36594529 | DOI:10.33963/KP.a2022.0288
Source: Kardiologia Polska - January 3, 2023 Category: Cardiology Authors: Radoslaw Wilimski Zenon Huczek Kajetan Grodecki Janusz Kochman Bartosz Rymuza Wojciech Wojakowski Damian Hudziak Dariusz Jagielak Jerzy Sacha Marek Grygier Andrzej Walczak Piotr Hendzel Romuald Cicho ń Marcin Grabowski Mariusz Ku śmierczyk Source Type: research

Non-vitamin K antagonist oral anticoagulants (NOACs) in the treatment of coronary and peripheral atherosclerosis. Expert Consensus.
Abstract Oral anticoagulants (OAC) are widely used for prevention of systemic thromboembolism, including the reduction of the risk of stroke in patients with atrial fibrillation (AF) and prosthetic heart valves. There is also an increasing population of patients who require not only OACs, but also double antiplatelet therapy (DAPT). A typical example is a patient with AF and stable coronary artery disease or acute coronary syndrome (ACS), treated by percutaneous coronary intervention (PCI). In recent years, with the introduction of NOACs, triple or dual therapy has become safer. Regardless of these indications for...
Source: Polish Heart Journal - February 25, 2019 Category: Cardiology Authors: Witkowski A, Barylski M, Filipiak KJ, Gierlotka M, Legutko J, Lesiak M, Stępińska J, Wojakowski W Tags: Kardiol Pol Source Type: research